Cancer statistics for adolescents and young adults, 2020

Kimberly D Miller, Miranda Fidler-Benaoudia, Theresa H Keegan, Heather S Hipp, Ahmedin Jemal, Rebecca L Siegel, Kimberly D Miller, Miranda Fidler-Benaoudia, Theresa H Keegan, Heather S Hipp, Ahmedin Jemal, Rebecca L Siegel

Abstract

Cancer statistics for adolescents and young adults (AYAs) (aged 15-39 years) are often presented in aggregate, masking important heterogeneity. The authors analyzed population-based cancer incidence and mortality for AYAs in the United States by age group (ages 15-19, 20-29, and 30-39 years), sex, and race/ethnicity. In 2020, there will be approximately 89,500 new cancer cases and 9270 cancer deaths in AYAs. Overall cancer incidence increased in all AYA age groups during the most recent decade (2007-2016), largely driven by thyroid cancer, which rose by approximately 3% annually among those aged 20 to 39 years and 4% among those aged 15 to 19 years. Incidence also increased in most age groups for several cancers linked to obesity, including kidney (3% annually across all age groups), uterine corpus (3% in the group aged 20-39 years), and colorectum (0.9%-1.5% in the group aged 20-39 years). Rates declined dramatically for melanoma in the group aged 15 to 29 years (4%-6% annually) but remained stable among those aged 30 to 39 years. Overall cancer mortality declined during 2008 through 2017 by 1% annually across age and sex groups, except for women aged 30 to 39 years, among whom rates were stable because of a flattening of declines in female breast cancer. Rates increased for cancers of the colorectum and uterine corpus in the group aged 30 to 39 years, mirroring incidence trends. Five-year relative survival in AYAs is similar across age groups for all cancers combined (range, 83%-86%) but varies widely for some cancers, such as acute lymphocytic leukemia (74% in the group aged 15-19 years vs 51% in the group aged 30-39 years) and brain tumors (77% vs 66%), reflecting differences in histologic subtype distribution and treatment. Progress in reducing cancer morbidity and mortality among AYAs could be addressed through more equitable access to health care, increasing clinical trial enrollment, expanding research, and greater alertness among clinicians and patients for early symptoms and signs of cancer. Further progress could be accelerated with increased disaggregation by age in research on surveillance, etiology, basic biology, and survivorship.

Keywords: adolescent cancer; childhood cancer; epidemiology; pediatric cancer.

© 2020 American Cancer Society.

References

    1. US Department of Health and Human Services. Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group. NIH publication 06-6067. US Department of Health and Human Services; 2006.
    1. Tricoli JV, Boardman LA, Patidar R, et al. A mutational comparison of adult and adolescent and young adult (AYA) colon cancer. Cancer. 2018;124:1070-1082.
    1. Tricoli JV, Blair DG, Anders CK, et al. Biologic and clinical characteristics of adolescent and young adult cancers: acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer. 2016;122:1017-1028.
    1. Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288-298.
    1. Chao C, Bhatia S, Xu L, et al. Incidence, risk factors, and mortality associated with second malignant neoplasms among survivors of adolescent and young adult cancer. JAMA Netw Open. 2019;2:e195536.
    1. Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016;122:116-123.
    1. Chao C, Xu L, Bhatia S, et al. Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA Cancer Survivors Study. J Clin Oncol. 2016;34:1626-1633.
    1. Olsson M, Enskar K, Steineck G, Wilderang U, Jarfelt M. Self-perceived physical attractiveness in relation to scars among adolescent and young adult cancer survivors: a population-based study. J Adolesc Young Adult Oncol. 2018;7:358-366.
    1. Suh E, Stratton KL, Leisenring WM, et al. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol. 2020;21:421-435.
    1. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148:516-523.
    1. Barr RD, Ferrari A, Ries L, Whelan J, Bleyer WA. Cancer in adolescents and young adults: a narrative review of the current status and a view of the future. JAMA Pediatr. 2016;170:495-501.
    1. Greene MH, Kratz CP, Mai PL, et al. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer. 2010;17:R109-R121.
    1. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140:317-322.
    1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data-Cancer in North America (CiNA) Analytic File, 1995-2016, for Expanded Races, Custom File With County, American Cancer Society Facts and Figures Projection Project (which includes data from the Centers for Disease Control and Prevention's National Program of Cancer Registries, the Canadian Council of Cancer Registries' Provincial and Territorial Registries, and the National Cancer Institute's SEER Registries). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2018.
    1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data-Cancer in North America (CiNA) Analytic File, 1995-2016, for the NAACCR Hispanic Identification Algorithm (NHIA) version 2 Origin, Custom File With County, American Cancer Society Facts and Figures Projection Project (which includes data from the Centers for Disease Control and Prevention's National Program of Cancer Registries, the Canadian Council of Cancer Registries' Provincial and Territorial Registries, and the National Cancer Institute's SEER Registries). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2018.
    1. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36:237-249.
    1. Arora RS, Alston RD, Eden TO, Geraci M, Birch JM. Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer. 2012;118:4290-4297.
    1. Nordsborg RB, Meliker JR, Wohlfahrt J, Melbye M, Raaschou-Nielsen O. Cancer in first-degree relatives and risk of testicular cancer in Denmark. Int J Cancer. 2011;129:2485-2491.
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7-30.
    1. Surveillance Research Program, National Cancer Institute. SEER*Stat Software. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2020.
    1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results (SEER) Incidence-US Cancer Statistics File for Delay Adjustment-1999-2016-jbk 072919 (created August 3, 2019). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2019.
    1. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. World Health Organization; 2000.
    1. Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006;106:1425-1430.
    1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision, Vols I-III. World Health Organization; 2011.
    1. National Cancer Institute. Joinpoint Regression Program, Version 4.7.0.0. Statistical Research and Applications Branch, National Cancer Institute; 2019.
    1. Jemal A, Miller KD, Ma J, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med. 2018;378:1999-2009.
    1. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317:1338-1348.
    1. Liu PH, Wu K, Ng K, et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 2019;5:37-44.
    1. Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4:e137-e147.
    1. King SC, Pollack LA, Li J, King JB, Master VA. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. J Urol. 2014;191:1665-1670.
    1. Siegel SE, Coccia PF, Barr R, Hayes-Lattin B, Bleyer A. RE: A reappraisal of sex-specific cancer survival trends among adolescents and young adults in the United States. J Natl Cancer Inst. 2019;111:633-634.
    1. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007;12:816-824.
    1. Tricoli JV, Seibel NL, Blair DG, Albritton K, Hayes-Lattin B. Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst. 2011;103:628-635.
    1. Bleyer A, Montello M, Budd T, Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer. 2005;103:1891-1897.
    1. DeRouen MC, Parsons HM, Kent EE, Pollock BH, Keegan THM. Sociodemographic disparities in survival for adolescents and young adults with cancer differ by health insurance status. Cancer Causes Control. 2017;28:841-851.
    1. Curtin SC, Minino AM, Anderson RN. Declines in Cancer Death Rates Among Children and Adolescents in the United States, 1999-2014. NCHS Data Brief, No. 257. National Center for Health Statistics; 2016.
    1. Zapotocky M, Ramaswamy V, Lassaletta A, Bouffet E. Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology. Pediatr Blood Cancer. 2018;65:26861.
    1. Ostrom QT, Adel Fahmideh M, Cote DJ, et al. Risk factors for childhood and adult primary brain tumors. Neuro Oncol. 2019;21:1357-1375.
    1. Withrow DR, de Gonzalez AB, Lam CJK, Warren KE, Shiels MS. Trends in pediatric central nervous system tumor incidence in the United States, 1998-2013. Cancer Epidemiol Biomarkers Prev. 2019;28:522-530.
    1. Li XR, Kruchko C, Wu XC, et al. Are benign and borderline brain tumors underreported? J Registry Manag. 2016;43:187-194.
    1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Registries Research Data + Hurricane Katrina Impacted Louisiana Cases, November 2018 Submission (2000-2016) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total US, 1969-2017 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2019.
    1. Lalloo F, Varley J, Moran A, et al. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer. 2006;42:1143-1150.
    1. Mai PL, Best AF, Peters JA, et al. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer. 2016;122:3673-3681.
    1. Dartois L, Fagherazzi G, Baglietto L, et al. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: estimates from the E3N-EPIC cohort. Int J Cancer. 2016;138:2415-2427.
    1. Warner ET, Colditz GA, Palmer JR, Partridge AH, Rosner BA, Tamimi RM. Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40? Breast Cancer Res Treat. 2013;142:165-175.
    1. DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438-451.
    1. Ruddy KJ, Gelber S, Tamimi RM, et al. Breast cancer presentation and diagnostic delays in young women. Cancer. 2014;120:20-25.
    1. Willauer AN, Liu Y, Pereira AAL, et al. Clinical and molecular characterization of early-onset colorectal cancer. Cancer. 2019;125:2002-2010.
    1. Bonadona V, Bonaiti B, Olschwang S, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304-2310.
    1. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006;101:385-398.
    1. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017;109:djw322.
    1. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145-165.
    1. Gupta S, Harper A, Ruan Y, et al. International trends in the incidence of cancer among adolescents and young adults. J Natl Cancer Inst. Published online February 4, 2020. doi:10.1093/jnci/djaa007
    1. Kantarjian HM, Keating MJ, Freireich EJ. Toward the potential cure of leukemias in the next decade. Cancer. 2018;124:4301-4313.
    1. Shao YH, Tsai H, Sinae K, Wu YJ, Demissie K. Exposure to tomographic scans and cancer risk. JNCI Cancer Spectr. 2020;4:pkz072.
    1. Morton LM, Swerdlow AJ, Schaapveld M, et al. Current knowledge and future research directions in treatment-related second primary malignancies. EJC Suppl. 2014;12:5-17.
    1. Castillo JJ, Reagan JL, Ingham RR, et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res. 2012;36:868-875.
    1. Muffly L, Alvarez E, Lichtensztajn D, Abrahao R, Gomez SL, Keegan T. Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study. Blood Adv. 2018;2:895-903.
    1. Jarrett RF. Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leuk Lymphoma. 2003;44(suppl 3):S27-S32.
    1. Teras LR, Rollison DE, Pawlita M, et al. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the Cancer Prevention Study-II and a meta-analysis of serologic studies. Int J Cancer. 2015;136:108-116.
    1. Altieri A, Bermejo JL, Hemminki K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood. 2005;106:668-672.
    1. Linabery AM, Erhardt EB, Richardson MR, et al. Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: a Children's Oncology Group study. Int J Cancer. 2015;137:2163-2174.
    1. Willett EV, Morton LM, Hartge P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008;122:2062-2070.
    1. Pol-Rodriquez M, Lee S, Silvers DN, Celebi JT. Influence of age on survival in childhood spitzoid melanomas. Cancer. 2007;109:1579-1583.
    1. Anderson WF, Pfeiffer RM, Tucker MA, Rosenberg PS. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer. 2009;115:4176-4185.
    1. Holman DM, Freeman MB, Shoemaker ML. Trends in melanoma incidence among non-Hispanic Whites in the United States, 2005 to 2014. JAMA Dermatol. 2018;154:361-362.
    1. Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4757.
    1. Lazovich D, Isaksson Vogel R, Weinstock MA, Nelson HH, Ahmed RL, Berwick M. Association between indoor tanning and melanoma in younger men and women. JAMA Dermatol. 2016;152:268-275.
    1. Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol. 2006;3:532-543.
    1. Morimoto LM, Zava D, McGlynn KA, et al. Neonatal hormone concentrations and risk of testicular germ cell tumors (TGCT). Cancer Epidemiol Biomarkers Prev. 2018;27:488-495.
    1. Vriens MR, Moses W, Weng J, et al. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 2011;117:259-267.
    1. Syrjanen K, Shabalova I, Petrovichev N, et al. Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Eur J Epidemiol. 2007;22:723-735.
    1. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370:1609-1621.
    1. Boersma P, Black LI. Human Papillomavirus Vaccination Among Adults Aged 18-26, 2013-2018. NCHS Data Brief, No. 354. National Center for Health Statistics; 2020.
    1. Benard VB, Watson M, Castle PE, Saraiya M. Cervical carcinoma rates among young females in the United States. Obstet Gynecol. 2012;120:1117-1123.
    1. Islami F, Fedewa SA, Jemal A. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States. Prev Med. 2019;123:316-323.
    1. White A, Thompson TD, White MC, et al. Cancer screening test use-United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:201-206.
    1. Barnett M, McDonnell G, DeRosa A, et al. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Surviv. 2016;10:814-831.
    1. Warner EL, Kent EE, Trevino KM, Parsons HM, Zebrack BJ, Kirchhoff AC. Social well-being among adolescents and young adults with cancer: a systematic review. Cancer. 2016;122:1029-1037.
    1. National Comprehensive Cancer Network. Adolescent and Young Adult (AYA) Oncology. NCCN Clinical Practice Guidelines in Oncology. Version 1.2020. National Comprehensive Cancer Network; 2019.
    1. Anderson C, Nichols HB. Trends in late mortality among adolescent and young adult cancer survivors. J Natl Cancer Inst. Published online March 3, 2020. doi:10.1093/jnci/djaa014
    1. Lang MJ, Giese-Davis J, Patton SB, Campbell DJT. Does age matter? Comparing post-treatment psychosocial outcomes in young adult and older adult cancer survivors with their cancer-free peers. Psychooncology. 2018;27:1404-1411.
    1. Bellizzi KM, Smith A, Schmidt S, et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118:5155-5162.
    1. Dieluweit U, Debatin KM, Grabow D, et al. Social outcomes of long-term survivors of adolescent cancer. Psychooncology. 2010;19:1277-1284.
    1. Zebrack B, Isaacson S. Psychosocial care of adolescent and young adult patients with cancer and survivors. J Clin Oncol. 2012;30:1221-1226.
    1. Olsson M, Steineck G, Enskar K, Wilderang U, Jarfelt M. Sexual function in adolescent and young adult cancer survivors-a population-based study. J Cancer Surviv. 2018;12:450-459.
    1. Keegan TH, Lichtensztajn DY, Kato I, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6:239-250.
    1. Shnorhavorian M, Harlan LC, Smith AW, et al. Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: a population-based study. Cancer. 2015;121:3499-3506.
    1. Guy GP Jr, Yabroff KR, Ekwueme DU, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff (Millwood). 2014;33:1024-1031.
    1. Berchick ER, Barnett JC, Upton RD. Current Population Reports, P60-267. Health Insurance Coverage in the United States: 2018. US Government Printing Office; 2019.
    1. Keegan THM, Parsons HM, Chen Y, et al. Impact of health insurance on stage at cancer diagnosis among adolescent and young adults. J Natl Cancer Inst. 2019;111:1152-1160.
    1. Zheng Z, Jemal A, Han X, et al. Medical financial hardship among cancer survivors in the United States. Cancer. 2019;125:1737-1747.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa